SFG
BNTX icon

SevenBridge Financial Group’s BioNTech BNTX Stock Holding History

SevenBridge Financial Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,570
Closed -$2.03M – 164
2021
Q1 		$2.03M Sell
18,570
-443
-2% -$47K 0.74% 40
2020
Q4 		$1.55M Sell
19,013
-50
-0.3% -$4.91K 0.61% 47
2020
Q3 		$1.32M Buy
19,063
+436
+2% +$31.3K 0.6% 54
2020
Q2 		$1.24M Buy
+18,627
New +$930K 0.62% 48

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

SevenBridge Financial Group's BNTX Position: Q2 2021 in Review

SevenBridge Financial Group sold out of BioNTech (BNTX) in Q2 2021, closing a stake of 18,570 shares — an estimated $2.03M sold.

SevenBridge Financial Group first reported a position in BNTX in Q2 2020 and held it in 4 quarters. The position peaked at $2.03M in Q1 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2021.

  • SevenBridge Financial Group reported no remaining BioNTech position as of Q2 2021 after selling out during the quarter.
  • SevenBridge Financial Group sold 18,570 BioNTech shares in Q2 2021, an estimated $2.03M.
  • SevenBridge Financial Group first reported a position in BioNTech in Q2 2020 and held it in 4 quarters.
  • SevenBridge Financial Group's BioNTech position peaked at $2.03M in Q1 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2021.

Based on SevenBridge Financial Group's 13F filing for Q2 2021, filed 26 Jul 2021.